These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 11159685)

  • 1. Characterization of KCNQ5/Q3 potassium channels expressed in mammalian cells.
    Wickenden AD; Zou A; Wagoner PK; Jegla T
    Br J Pharmacol; 2001 Jan; 132(2):381-4. PubMed ID: 11159685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retigabine, a novel anti-convulsant, enhances activation of KCNQ2/Q3 potassium channels.
    Wickenden AD; Yu W; Zou A; Jegla T; Wagoner PK
    Mol Pharmacol; 2000 Sep; 58(3):591-600. PubMed ID: 10953053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of KCNQ2/3 potassium channels by the novel anticonvulsant retigabine.
    Main MJ; Cryan JE; Dupere JR; Cox B; Clare JJ; Burbidge SA
    Mol Pharmacol; 2000 Aug; 58(2):253-62. PubMed ID: 10908292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of expressed KCNQ potassium currents and native neuronal M-type potassium currents by the anti-convulsant drug retigabine.
    Tatulian L; Delmas P; Abogadie FC; Brown DA
    J Neurosci; 2001 Aug; 21(15):5535-45. PubMed ID: 11466425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meclofenamic acid and diclofenac, novel templates of KCNQ2/Q3 potassium channel openers, depress cortical neuron activity and exhibit anticonvulsant properties.
    Peretz A; Degani N; Nachman R; Uziyel Y; Gibor G; Shabat D; Attali B
    Mol Pharmacol; 2005 Apr; 67(4):1053-66. PubMed ID: 15598972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-(6-chloro-pyridin-3-yl)-3,4-difluoro-benzamide (ICA-27243): a novel, selective KCNQ2/Q3 potassium channel activator.
    Wickenden AD; Krajewski JL; London B; Wagoner PK; Wilson WA; Clark S; Roeloffs R; McNaughton-Smith G; Rigdon GC
    Mol Pharmacol; 2008 Mar; 73(3):977-86. PubMed ID: 18089837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retigabine stimulates human KCNQ2/Q3 channels in the presence of bupivacaine.
    Punke MA; Friederich P
    Anesthesiology; 2004 Aug; 101(2):430-8. PubMed ID: 15277926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the KCNQ potassium channel opener retigabine on single KCNQ2/3 channels expressed in CHO cells.
    Tatulian L; Brown DA
    J Physiol; 2003 May; 549(Pt 1):57-63. PubMed ID: 12702739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The novel anticonvulsant retigabine activates M-currents in Chinese hamster ovary-cells tranfected with human KCNQ2/3 subunits.
    Rundfeldt C; Netzer R
    Neurosci Lett; 2000 Mar; 282(1-2):73-6. PubMed ID: 10713399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of KCNQ5 channels stably expressed in HEK293 cells by BMS-204352.
    Dupuis DS; Schrøder RL; Jespersen T; Christensen JK; Christophersen P; Jensen BS; Olesen SP
    Eur J Pharmacol; 2002 Feb; 437(3):129-37. PubMed ID: 11890900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KCNQ4 channel activation by BMS-204352 and retigabine.
    Schrøder RL; Jespersen T; Christophersen P; Strøbaek D; Jensen BS; Olesen SP
    Neuropharmacology; 2001 Jun; 40(7):888-98. PubMed ID: 11378159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anxiolytic effects of Maxipost (BMS-204352) and retigabine via activation of neuronal Kv7 channels.
    Korsgaard MP; Hartz BP; Brown WD; Ahring PK; Strøbaek D; Mirza NR
    J Pharmacol Exp Ther; 2005 Jul; 314(1):282-92. PubMed ID: 15814569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular correlates of the M-current in cultured rat hippocampal neurons.
    Shah M; Mistry M; Marsh SJ; Brown DA; Delmas P
    J Physiol; 2002 Oct; 544(Pt 1):29-37. PubMed ID: 12356878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a novel Kv1.5 channel blocker in Xenopus oocytes, CHO cells, human and rat cardiomyocytes.
    Bachmann A; Gutcher I; Kopp K; Brendel J; Bosch RF; Busch AE; Gögelein H
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Nov; 364(5):472-8. PubMed ID: 11692231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An osmosensitive voltage-gated K+ current in rat supraoptic neurons.
    Zhang W; Wang D; Liu XH; Kosala WR; Rajapaksha JS; Fisher TE
    Eur J Neurosci; 2009 Jun; 29(12):2335-46. PubMed ID: 19490083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stoichiometry of expressed KCNQ2/KCNQ3 potassium channels and subunit composition of native ganglionic M channels deduced from block by tetraethylammonium.
    Hadley JK; Passmore GM; Tatulian L; Al-Qatari M; Ye F; Wickenden AD; Brown DA
    J Neurosci; 2003 Jun; 23(12):5012-9. PubMed ID: 12832524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-channel analysis of KCNQ K+ channels reveals the mechanism of augmentation by a cysteine-modifying reagent.
    Li Y; Gamper N; Shapiro MS
    J Neurosci; 2004 Jun; 24(22):5079-90. PubMed ID: 15175377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of ERG channels by XE991.
    Elmedyb P; Calloe K; Schmitt N; Hansen RS; Grunnet M; Olesen SP
    Basic Clin Pharmacol Toxicol; 2007 May; 100(5):316-22. PubMed ID: 17448117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular cloning and functional expression of KCNQ5, a potassium channel subunit that may contribute to neuronal M-current diversity.
    Lerche C; Scherer CR; Seebohm G; Derst C; Wei AD; Busch AE; Steinmeyer K
    J Biol Chem; 2000 Jul; 275(29):22395-400. PubMed ID: 10787416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The anti-hyperalgesic activity of retigabine is mediated by KCNQ potassium channel activation.
    Dost R; Rostock A; Rundfeldt C
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Apr; 369(4):382-90. PubMed ID: 15007538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.